BVXV · BiondVax Pharmaceuticals Ltd ADR

-

-

Please sign in to comment on BVXV

1 Comment

Admin
4 years ago

BiondVax Pharmaceuticals Ltd is currently in a long term downtrend where the price is trading 56.9% below its 200 day moving average.

From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.

BiondVax Pharmaceuticals Ltd's total revenue sank by nan% to $0 since the same quarter in the previous year.

Its net income has increased by 385.8% to $55M since the same quarter in the previous year.

Finally, its free cash flow grew by 79.4% to $-14M since the same quarter in the previous year.

Based on the above factors, BiondVax Pharmaceuticals Ltd gets an overall score of 3/5.












© PyInvesting 2025

About    Blog    Influencers   Careers   Contact Us   Disclaimer   Privacy Policy